America’s leading congress for diagnostics, precision medicine, and digital transformation in pharmaceutical development and healthcare. Join 1500+ leaders in Boston to explore breakthroughs in multiomic data, AI, genomics, and digital health in the
Artificial intelligence and machine learning are transforming drug discovery and development, from target identification and candidate screening to predictive modelling, study desi…
Background: Traditional clinical trial evaluations heavily rely on the Average Treatment Effect (ATE), a metric that can obscure substantial heterogeneity in individual patient res…
An audience of 7 companies, parsed from the program.
The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.
71% of the speakers carry senior titles: C-suite, Founder, VP, or Director-level.
Of 7 on the bill · classified by free-text title
Tiers were not disclosed for this event.